๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Azathioprine in the treatment of myasthenia gravis

โœ Scribed by Arnold S. Witte; David R. Cornblath; Gareth J. Parry; Robert P. Lisak; Norman J. Schatz


Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
594 KB
Volume
15
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Immunoglobulin treatment in refractory m
โœ Anat Achiron; Yoram Barak; Shmuel Miron; Ida Sarova-Pinhas ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 134 KB ๐Ÿ‘ 2 views

Failure to induce and maintain remission in severe exacerbations of myasthenia gravis (MG), despite optimal care, is a common problem. We evaluated the efficacy and safety of high-dose intravenous immunoglobulin (IVIg) therapy in an open-label study of 10 patients with severe generalized myasthenia

Long-term treatment of myasthenia gravis
โœ Martin Haas; Norbert Mayr; Josef Zeitlhofer; Andreas Goldammer; Kurt Derfler ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB

Acute treatment of myasthenic crisis with immunoadsorption (IA) or plasma exchange is well established. The efficiency of chronic apheresis therapy in myasthenia gravis (MG), however, and its efficacy in reducing concomitant potentially harmful immunosuppressive therapy, is unknown. We treated 13 pa

Myasthenia gravis in the tenth decade
โœ Lawrence H. Phillips II; Vern C. Juel ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 3 views
Prediction of aspiration in myasthenia g
โœ Wilma J. Koopman; Samuel Wiebe; Angela Colton-Hudson; Tas Moosa; Dean Smith; Dav ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB